I’ve written several posts with a variation on the title Bad News For Statins. Those have mostly pointed out the nasty side effects of statins. Doctors who push statins usually dismiss those side effects as a small price to avoid a heart attack – which they insist statins help us do.
But what if statins actually harm our hearts instead of protecting them? That’s what new research says they do. Let’s start by looking at some quotes from an article in the U.K. Express:
People taking the drugs are more likely to suffer from hardening of the arteries, a leading cause of heart problems. In addition, researchers found the drugs block a process that protects the heart. This can “cause, or worsen, heart failure”, according to a study.
Dr Okuyama, of Nagoya City University, Japan, said: “We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure. I cannot find any evidence to support people taking statins and patients who are on them should stop.”
But wait … haven’t there been big ol’ studies demonstrating that statins prevent heart attacks? Well, yes, there were some of those — conducted and reported many years ago by the statin-makers. The current study’s lead researcher believes that was a wee bit of a problem:
Dr Okuyama and his team say many earlier industry-sponsored studies, which show the benefits of statins, are unreliable. They claim this is because they were carried out before new European regulations were introduced in 2004 which insisted on all trial findings, both negative and positive, being declared.
The study states that before these new rules came into effect “unfair and unethical problems were associated with clinical trials reported by industry-supported scientists”.
Dr Okuyama’s team looked at studies before and after 2004.
So they compared both old and new studies, since statin-makers are no longer allowed to just bury the results they don’t like. Here’s what Dr. Okuyama’s group concluded in their analysis:
The researchers say the hypothesis that statins protect the heart by lowering cholesterol is flawed and that high cholesterol is not necessarily linked to heart disease.
They also found statins have a negative effect on vital body processes linked to heart health.
They discovered patients taking the drugs were more likely to have calcium deposits in their arteries, a phenomenon directly linked to heart attacks.
Dr Peter Langsjoen, a heart specialist based in Texas who is co-author of the study, said: “Statins are being used so aggressively and in such large numbers of people that the adverse effects are now becoming obvious. These drugs should never have been approved for use. The long-term effects are devastating.”
Meanwhile, the American Heart Association is (of course) still pushing new guidelines that would make even more people eligible for statins. Here are some quotes from a Medscape article I linked in a post about those guidelines back in 2014:
The new American College of Cardiology (ACC) and American Heart Association (AHA) guidelines for the treatment of cholesterol would increase the number of individuals eligible for statin therapy by nearly 13 million people, an increase that is largely driven by older patients and treating individuals without cardiovascular disease, according to a new analysis.
Among older adults, those aged 60 to 75 years old, 87.4% of men would now be eligible for the lipid-lowering medication, which is up from one-third under the old Adult Treatment Panel (ATP) III guidelines. For women of the same age, the percentage of those now eligible for statins would increase from 21.2% under ATP III to 53.6% with the new 2013 clinical guidelines.
So those guidelines would double the number of women over 60 taking statins and nearly triple the number of men in the same age group. Yup, just what the old folks need: more muscle and joint problems, higher blood sugar, and (if the new study is correct), accelerated hardening of their arteries. Way to go, American Heart Association.
A reader who sent me the link to the U.K. Express article commented in his email, Even after being destroyed with factual information, The Anointed reject what’s best and continue their destructive ways. Just what will make these people change their minds?
The answer is: nothing. Remember, part of what makes them The Anointed is the inability to believe they’re ever wrong. A couple of them are quoted, in fact, in the Express article:
A spokesman for the MHRA, the Government drug regulator, said: “The benefits of statins are well established and are considered to outweigh the risk of side effects in the majority of patients. Any new significant information on the efficacy of statins will be carefully reviewed and action be taken if required”.
Translation: we’ll pretend this study doesn’t exist and go on our merry, statin-pushing way.
Oxford professor Sir Rory Collins has warned that overstating concerns about statins could “cause very large numbers of unnecessary deaths from heart attacks and stroke”.
Oh, I don’t think it’s necessary for us to overstate the concerns about statins, Sir Rory. Merely pointing out the facts should convince intelligent people to stop taking these horrible drugs. Then they’ll avoid very large numbers of unnecessary cases of diabetes, liver damage, muscle damage, joint damage, and memory loss.
Pharmacological evidence and clinical trial results support the interpretation that statins stimulate atherogenesis by suppressing vitamin K2 synthesis and thereby enhancing artery calcification. Statins cause heart failure by depleting the myocardium of CoQ10, ‘heme A’ and selenoproteins, thereby impairing mitochondrial ATP production. In summary, statins are not only ineffective in preventing CHD events but instead are capable of increasing CHD and heart failure.
Physicians who are involved in prescribing cholesterol-lowering medications cannot ignore the moral responsibility of ‘informed consent’. Patients must be informed of all statin adverse effects, including the ability to cause CHD and heart failure, onset of diabetes mellitus, carcinogenicity, teratogenicity and central and peripheral nervous disorders besides the well-known rhabdomyolysis and hepatic injury. Most of these adverse effects of statins become apparent after 6 or more years of statin therapy. Chronic administration could ultimately lead to these statin adverse effects as pharmaceutical and biochemical research has now demonstrated.
I’d suggest you give the study a look. Better yet, send it to your statin-taking friends and relatives. You might just save them a world of hurt.